Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis
Article in Yonsei Medical Journal (November 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Article in Clinical Rheumatology (September 2023)
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Article in Advances in Rheumatology (June 2023)